Growth Metrics

Scholar Rock Holding (SRRK) Cash & Equivalents (2017 - 2026)

Scholar Rock Holding's quarterly Cash & Equivalents came in at $430.5 million in Q1 2026, up 212.16% year-on-year from $137.9 million in Q1 2025, and up 33.08% quarter-over-quarter from $323.5 million in Q4 2025.

Scholar Rock Holding has reported Cash & Equivalents for 10 years, with the latest figure at $430.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Equivalents rose 212.16% year-over-year to $430.5 million; the trailing twelve-month figure through Mar 2026 stood at $430.5 million (up 212.16% YoY), and the FY2025 full-year result was $323.5 million, up 81.88% from the prior year.
  • Cash & Equivalents for Q1 2026 stood at $430.5 million, up from $323.5 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $430.5 million in Q1 2026, with the low at $67.6 million in Q3 2023.
  • Average Cash & Equivalents over 5 years is $167.2 million, with a median of $133.1 million recorded in 2022.
  • Year-over-year, Cash & Equivalents slumped 64.65% in 2023 and surged 275.4% in 2025.
  • Tracing SRRK's Cash & Equivalents over 5 years: stood at $103.3 million in 2022, then dropped by 1.37% to $101.9 million in 2023, then jumped by 74.64% to $177.9 million in 2024, then surged by 81.88% to $323.5 million in 2025, then jumped by 33.08% to $430.5 million in 2026.
  • The last three Cash & Equivalents figures came in at $430.5 million (Q1 2026), $323.5 million (Q4 2025), and $286.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 1.91 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 32.30 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 286.70 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 61.46 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 2.77 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 5.49 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 18.44 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.96 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.71 Bn
10 Scholar Rock Holding 500.61 Mn 20.67 Mn - 430.54 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 430.54 Mn
Dec 31, 2025 323.53 Mn
Sep 30, 2025 286.77 Mn
Jun 30, 2025 152.93 Mn
Mar 31, 2025 137.93 Mn
Dec 31, 2024 177.88 Mn
Sep 30, 2024 76.39 Mn
Jun 30, 2024 93.37 Mn
Mar 31, 2024 91.98 Mn
Dec 31, 2023 101.86 Mn
Sep 30, 2023 67.60 Mn
Jun 30, 2023 108.06 Mn
Mar 31, 2023 151.28 Mn
Dec 31, 2022 103.28 Mn
Sep 30, 2022 133.08 Mn
Jun 30, 2022 305.73 Mn
Mar 31, 2022 100.18 Mn
Dec 31, 2021 212.84 Mn
Sep 30, 2021 176.13 Mn
Jun 30, 2021 206.92 Mn
Mar 31, 2021 159.11 Mn
Dec 31, 2020 160.36 Mn
Sep 30, 2020 56.23 Mn
Jun 30, 2020 115.13 Mn
Mar 31, 2020 95.43 Mn
Dec 31, 2019 36.31 Mn
Sep 30, 2019 32.64 Mn
Jun 30, 2019 113.80 Mn
Mar 31, 2019 67.00 Mn
Dec 31, 2018 115.07 Mn
Sep 30, 2018 103.99 Mn
Jun 30, 2018 115.06 Mn
Dec 31, 2017 56.46 Mn